Related Experiment Video
Updated: Aug 8, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Circulating HPV DNA in HPV-associated cancers.
1National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, PR China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, PR China; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, PR China.
Circulating human papillomavirus DNA (cHPV-DNA) shows promise as a biomarker for detecting and monitoring HPV-driven cancers. Further clinical trials are needed to confirm its utility in screening, diagnosis, and treatment across the cancer care continuum.
Area of Science:
- Oncology
- Virology
- Biomarker Discovery
Background:
- Human papillomavirus (HPV) infections are a leading cause of various cancers, including cervical, anal, and head and neck malignancies.
- Circulating HPV DNA (cHPV-DNA) is an emerging biomarker with significant potential in managing HPV-associated cancers.
- Advancements in cHPV-DNA detection techniques are rapidly evolving for cancer management.
Purpose of the Study:
- To review the current applications of cHPV-DNA liquid biopsies in HPV-driven cancer care.
- To highlight the diagnostic potential of cHPV-DNA.
- To identify future research directions for integrating cHPV-DNA into clinical practice.
Main Methods:
- Review of current literature on cHPV-DNA applications.
- Analysis of advancements in cHPV-DNA detection and characterization techniques.
- Examination of clinical trial data assessing cHPV-DNA utility.
Main Results:
- cHPV-DNA is increasingly recognized as a valuable biomarker for HPV-related cancers.
- Liquid biopsies utilizing cHPV-DNA show potential for cancer detection, characterization, and monitoring.
- Clinical evidence supports the diagnostic utility of cHPV-DNA.
Conclusions:
- cHPV-DNA liquid biopsies offer a promising avenue for managing HPV-driven malignancies.
- Further clinical trials are essential to validate the full potential of cHPV-DNA in screening, diagnosis, and treatment.
- Integration of cHPV-DNA testing into clinical practice holds significant future opportunities.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
Cancer Prevention
Some...

